Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985).
暂无分享,去创建一个
S. Walker | R. A. Prentis | Y. Lis | R A Prentis | Y Lis | S R Walker | RA Prentis | SR Walker
[1] G. Diggle,et al. A survey of products licensed in the United Kingdom from 1971-1981. , 1981, British journal of clinical pharmacology.
[2] N. Mattison,et al. The development of self-originated new drugs by Swiss pharmaceutical firms, 1960-1980. , 1984, Regulatory toxicology and pharmacology : RTP.
[3] W. Wardell,et al. The Measurement of Pharmaceutical Innovation , 1980, Journal of clinical pharmacology.
[4] S. Walker,et al. Trends in the development of new medicines by UK-owned pharmaceutical companies (1964-1980). , 1986, British journal of clinical pharmacology.
[5] C. Speirs,et al. A survey of the first year of operation of the new procedure affecting the conduct of clinical trials in the United Kingdom. , 1983, British journal of clinical pharmacology.
[6] A. Stewart,et al. Six months experience of new procedures affecting the conduct of clinical trials in the United Kingdom. , 1982, British journal of clinical pharmacology.
[7] W. Wardell,et al. The rate of development of new drugs in the United States, 1963 through 1975 , 1978, Clinical pharmacology and therapeutics.
[8] F. Steward,et al. Drug innovation—what's slowing it down? , 1980, Nature.
[9] Louis Lasagna,et al. New drug development in the United States, 1963 through 1984 , 1988, Clinical pharmacology and therapeutics.